FBIO - Fortress Biotech, Inc.
1.69
0 0%
Share volume: 116,091
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.69
0.00
0.00%
Summary score
18%
Profitability
0%
Dept financing
23%
Liquidity
75%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-36.37%
Return on assets
-9.13%
Return on sales
-157.9%
Return on invested capital
-64.78%
Total debt ratio
81.28%
Debt ratio change over timeo
0%
Current Ratio
3.23%
Quick Ratio
3.22%
Cash Position Ratio
2.59%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-32.59%
Return on assets
-10.08%
Return on sales
-239.86%
Return on invested capital
-79.57%
Total debt ratio
79.2%
Debt ratio change over timeo
0%
Current Ratio
4.09%
Quick Ratio
4.07%
Cash Position Ratio
3.59%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-16.01%
Return on assets
-8.05%
Return on sales
-251.27%
Return on invested capital
-74.53%
Total debt ratio
67.18%
Debt ratio change over time
0%
Current Ratio
6.38%
Quick Ratio
6.35%
Cash Position Ratio
5.86%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FBIO | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -36.37% | 18.71% | 4.67% | 19.62% |
| Return on assets | -9.13% | 3.4% | 3.32% | 11.24% |
| Return on sales | -157.9% | 24.27% | 25.81% | 41.89% |
| Return on invested capital | -64.78% | 5.38% | 4.17% | -280.52% |
| Profitability | 0% | 71% | 48% | 75% |
| Total debt ratio | 81.28% | 78.91% | 58.54% | 54.01% |
| Debt ratio change over time | 0% | 0% | 10.69% | 0% |
| Dept financing | 25% | 24% | 43% | 17% |
| Current Ratio | 4.09% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 4.07% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 3.59% | 0.21% | 0.6% | 0.32% |
| Liquididy | 75% | 21% | 28% | 18% |
| Short-term ratios | FBIO | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -32.59% | 41.05% | 6.87% | 16.13% |
| Return on assets | -10.08% | 3.67% | 3.13% | 8.75% |
| Return on sales | -239.86% | 26.16% | 24.75% | 38.84% |
| Return on invested capital | -79.57% | 9.43% | 5.58% | -6.74% |
| Profitability | 0% | 77% | 44% | 60% |
| Total debt ratio | 79.2% | 91.28% | 61.3% | 55.02% |
| Debt ratio change over time | 0% | 0% | 13.89% | 0% |
| Dept financing | 22% | 25% | 42% | 15% |
| Current Ratio | 4.09% | 1.21% | 1.33% | 1.08% |
| Quick Ratio | 4.07% | 0.94% | 1.07% | 0.79% |
| Cash Position Ratio | 3.59% | 0.21% | 0.6% | 0.32% |
| Liquididy | 75% | 15% | 19% | 14% |
